In this study, albiforin evidently improved the clinical symptoms of colitis mice by preventing the loss of bodyweights, extending the lengths of colon, down-regulating the infiltration of inflammatory cells and inhibiting the accumulation of MDA and MPO and secretion of inflammatory cytokines including IL-1β, IL-6 and TNF-α. This evidence concerns the gene MPO and colitis.